Anagrelide 62135-0313
Product NDC
62135-0313- Manufacturer
- Chartwell Rx, Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 18, 2005
- Listing Expires
- December 31, 2026
- Application
- ANDA076683
Need to source Anagrelide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Anagrelide Hydrochloride Anhydrous | 1 mg/1 |
Drug Class
Decreased Platelet Production [PE]Phosphodiesterase 3 Inhibitors [MoA]Platelet-reducing Agent [EPC]
Packaging Options(1)
60 CAPSULE in 1 BOTTLE (62135-313-60)